20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7428 | SBI-115 | GPCR19 | |
SBI-115 is an antagonist of TGR5. SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5 | |||
T4083 | BAR501 | BAR 501 | GPCR19 |
BAR501 is an effective and specific GPBAR1 agonist (EC50: 1 μM). | |||
TQ0252 | BAR502 | FXR , GPCR19 , Autophagy | |
BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM). | |||
T4352 | SB756050 | SB-756050,SB 756050 | GPCR19 |
SB756050 is a specific TGR5 agonist. | |||
T2088 | APD668 | APD 668 | GPR , P450 , Potassium Channel |
APD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119, respectively. | |||
T5077 | Deoxycholic acid sodium salt | Sodium deoxycholate,Sodium Desoxycholate | Endogenous Metabolite , GPCR19 |
Deoxycholic acid sodium salt (Sodium deoxycholate) can activate the G protein-coupled bile acid receptor TGR5 that stimulates brown adipose tissue (BAT) thermogenic activity. | |||
T2965 | Deoxycholic acid | Cholorebic,Deoxycholate,Desoxycholic acid,Cholanoic Acid,Cholerebic | Endogenous Metabolite , GPCR19 |
Deoxycholic acid (Cholanoic Acid) is a bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorptio... | |||
TN2268 | Tetrahydromagnolol | Cannabinoid Receptor , GPR , GABA Receptor | |
Tetrahydromagnolol can activate cannabinoid (CB) receptors. | |||
T16378 | Ogerin | Others , 5-HT Receptor , Adenosine Receptor | |
Ogerin is a selective GPR68 positive allosteric modulator (pEC50: 6.83). Ogerin blocks recall in fear conditioning in mice. Ogerin displays inverse agonist and antagonist activity (Ki, 220 nM) at A2A receptor and weak an... | |||
T8818 | TC-G 1005 | GPCR19 | |
TC-G 1005 is a potent and selective GPBA agonist (EC50 :0.72 nM; hTGR5). Selective for TGR5 over FXR (farnesoid X receptor). Increases plasma GLP-1 levels and reduces blood glucose in mice. Orally available. | |||
T1793 | MBX-2982 | GPR | |
MBX-2982 is a selective, orally-available GPR119 agonist, used for the treatment of diabetes. | |||
T8425 | Linoleoyl Ethanolamide | TRP/TRPV Channel | |
Linoleoyl Ethanolamide is an endocannabinoid agent. It acts by binding to TRPV1 increasing ERK phosphorylation and AP-1 dependent transcription in CB-receptor in an independent manner. | |||
T21874 | CID 2745687 | GPR | |
CID 2745687 is a GPR35 antagonist that inhibited the effects at human GPR35 of cromolyn disodium and zaprinast, two agonists that share an overlapping binding site. | |||
T0700 | Ursodeoxycholic acid | UDCA,Ursodiol | Potassium Channel , Endogenous Metabolite |
Ursodeoxycholic acid (UDCA) can be used to dissolve gallstones and reduce cholesterol absorption. | |||
T2701 | GSK1292263 | GPR | |
GSK1292263 is a GPR119 agonist and has been investigated for the treatment of DIABETES MELLITUS, TYPE 2. | |||
T1824 | TGR5 Receptor Agonist | GPCR19 | |
TGR5 is a potent TGR5(GPCR19) agonist. | |||
T22996 | ML-191 | ERK | |
ML-191 is an inhibitor of LPI-induced phosphorylation of ERK1/2. | |||
T8329 | AR 231453 | GPR | |
AR 231453 is a selective and orally available GPR119 agonist,can stimulate β-cell replication and improve islet graft function. | |||
T4626 | TC-O 9311 free base | GPR | |
TC-O 9311 is a potent GPR139 agonist. | |||
T2968 | Hyodeoxycholic acid | NSC 60672,α-Hyodeoxycholic Acid,HDCA | FXR , Endogenous Metabolite , GPCR19 |
Hyodeoxycholic acid (NSC 60672) has been used in trials studying the treatment of Hypercholesterolemia. |